Volume 23.1 of the JMCM is now available. FEATURED ARTICLES INCLUDE: Recent Advances in the Treatment and Management of Moderate-to-Severe Atopic Dermatitis:What’s New in Biologic Therapies. Expanding Options in the Treatment of Prostate Cancer:The Impact of Prognostic Biomarkers on Patient Outcomes. New Advances in the Diagnosis and Treatment of Narcolepsy.
Current Issue Article:
Clinical Advances and Therapeutic Strategies
Because so many disease modifying therapies (DMT) have been approved for MS since the early 1990s, it can be difficult for managed care to keep up with all of them and to know how to manage use with each one. The decision process for clinicians to choose an agent is also difficult. Additionally, there are more therapies on the horizon.
Managed Care eNews
‘Dishing’ out a new test to improve breast cancer treatment
Multibrief Exclusive
Excluding cancers of the skin, breast cancer is the most common cancer among women in the United States, accounting for 29 percent of newly diagnosed cancers. Breast cancer incidence and death rates generally increase with age, and 79 percent of new cases and 88 percent of breast cancer deaths occur in women 50 years of age and older.
Genomics Biotech and Emerging Medical Technologies
Massive study reveals schizophrenia’s genetic roots
Scientific American
Schizophrenia is a distressing disorder involving hallucinations, delusions, paranoia and agitation. It affects around one in 100 people in the U.S., with symptoms usually first appearing between the ages of 16 and 30. Its causes have long been debated, particularly regarding whether genetics plays a role. It is known to be highly heritable, but small sample sizes and other methodology hurdles stymied early attempts to discern a genetic link.
Prevention, Lifestyle & Wellness
The sneaky cause of your sugar cravings
Yahoo Health
Sugar can’t catch a break these days. With everyone from from HBO comedian John Oliver to Yahoo’s Global New Anchor Katie Couric bashing sugar’s vice-like grip on the modern diet, more and more people are deciding to ditch it. The problem? It’s really, really difficult.
